DRG Stimulation for Focal Pain: What Makes It Different From Spinal Cord Stimulation
By Jackie Weisbein, DO
Board-Certified in Physical Medicine & Rehabilitation and Pain Medicine, Fellowship-Trained in Interventional Pain Management
Quick Insights:
Dorsal root ganglion stimulation, often called DRG stimulation, is a newer form of neuromodulation that targets specific sensory nerve clusters to treat focal neuropathic pain in areas like the foot, knee, groin, and hand, regions where traditional spinal cord stimulation can fall short. Unlike spinal cord stimulation, which delivers broader coverage along the spinal cord, DRG therapy places small leads at the dorsal root ganglion to provide precise, targeted relief with less variation when you change body position. For patients with complex regional pain syndrome, post-surgical neuropathic pain, or other focal nerve injuries who have not responded to conservative care, research suggests DRG stimulation offers a clinically distinct alternative with growing evidence of better outcomes in specific pain distributions.
Key Takeaways
- DRG stimulation targets the dorsal root ganglion, a sensory nerve cluster just outside the spinal cord, which allows for more precise focal pain relief than traditional spinal cord stimulation.
- Research indicates DRG therapy can achieve higher treatment-success rates than traditional spinal cord stimulation for complex regional pain syndrome and focal lower-extremity pain, with more consistent coverage regardless of body position.
- Studies suggest DRG is particularly suited for pain locations including the foot, knee, groin, and hand, where traditional spinal cord stimulation has historically produced inconsistent results.
- Like all neuromodulation therapies, DRG requires a brief trial period to confirm effectiveness before permanent implantation, and candidacy depends on pain distribution and prior treatment response.
Why It Matters:
For active adults managing chronic focal pain while juggling demanding careers, vineyard work, or weekend hikes, the difference between broad and precisely targeted pain relief can decide quality of life. When complex regional pain syndrome in one foot limits walking, groin pain after surgery affects daily movement, or knee pain lingers despite conservative care, the question is not simply "which device" but "which therapy matches my pain pattern." DRG stimulation reflects a shift toward precision in interventional pain management: matching the therapy to the exact location and character of your pain rather than applying one-size-fits-all coverage.
Understanding DRG Stimulation: A Targeted Approach to Focal Neuropathic Pain
When focal neuropathic pain affects one specific region, like the foot, knee, or groin, the obvious next question is why one neuromodulation approach can work better than another for that exact location. The landmark comparative evidence comes from the ACCURATE trial (discussed in detail below), which showed dorsal root ganglion stimulation achieved a higher treatment success rate than traditional spinal cord stimulation for complex regional pain syndrome and causalgia of the lower extremities at both 3 and 12 months. As a fellowship-trained interventional pain specialist and one of the nation's Top 100 neuromodulation implanters, I want to walk you through how DRG works differently at a physiologic level, which pain conditions tend to benefit most, what makes someone a candidate, and what the trial process actually involves.
Chronic neuropathic pain is exhausting, physically and emotionally, and patients often arrive in my office after years of trying treatments that did not deliver the targeted relief they needed. You are not alone in this, and the picture is more hopeful than it may feel right now.
Important Safety Information
DRG stimulation is an interventional procedure that requires surgical implantation. It carries risks such as infection, lead migration, and device-related complications. It is not appropriate for patients with active infections, certain bleeding disorders, or anyone who cannot complete the trial period. Patients on anticoagulation need careful peri-procedural management.
Anyone considering neuromodulation should have a comprehensive evaluation to confirm the focal neuropathic pain diagnosis and to ensure conservative treatments have been appropriately tried. This is not a first-line therapy; it is reserved for patients with refractory focal neuropathic pain who meet specific candidacy criteria.
How DRG Stimulation Works: Targeting the Nerve Cluster, Not the Spinal Cord
The physiologic difference between DRG and traditional spinal cord stimulation starts with anatomy. The dorsal root ganglion is a cluster of sensory nerve cell bodies that sits just outside the spinal cord in the intervertebral foramen, which is a distinct anatomical target from the dorsal columns of the spinal cord where traditional spinal cord stimulator leads are placed. DRG stimulation delivers electrical pulses directly to this nerve cluster, modulating pain signals at their entry point before they travel north to the brain.
Imagine the nervous system as a network of highways. Pain signals from your foot or groin merge onto the spinal highway at a specific on-ramp. The dorsal root ganglion is that on-ramp, and DRG stimulation works right at it, not further upstream. Because each ganglion serves a defined dermatomal region, leads can be placed at the exact level corresponding to your painful area. The result is focal coverage without the broader, less targeted stimulation pattern of traditional spinal cord stimulation. The NANS DRG overview provides foundational education on this mechanism for patients and clinicians.
A 2021 systematic review in J Clin Med notes that while multiple supraspinal mechanisms have been proposed for both spinal cord stimulation and DRG, the evidence regarding which central pathways are most active is mixed. In other words, the clinical outcomes are clearer than the complete mechanistic picture. For our purposes here, the clinical advantage is anatomical: DRG's location outside the spinal cord and its segmental organization make it inherently better suited for focal pain distributions.
Three Key Advantages of DRG Over Traditional Spinal Cord Stimulation
Precise Focal Targeting for Specific Pain Regions
Because each ganglion maps to a defined dermatome, DRG allows targeted therapy for pain limited to the foot, knee, groin, or hand, regions where traditional spinal cord stimulation can produce incomplete or inconsistent coverage. Placing a lead at the exact dorsal root ganglion that supplies the painful area is like aiming a spotlight on the spot that actually hurts, rather than turning up the room lights and hoping the painful spot is included. A single-center prospective study published in Neuromodulation 2017 reported meaningful, durable pain relief in patients with chronic neuropathic groin pain, an area notoriously difficult to cover with traditional spinal cord stimulation.
Reduced Postural Variation in Stimulation Coverage
One clinically significant difference: DRG stimulation produces more consistent coverage regardless of body position. With traditional spinal cord stimulation, moving from lying down to sitting or standing can shift the lead relative to the spinal cord and cause stimulation intensity to vary, sometimes uncomfortably. The dorsal root ganglion is anchored in the intervertebral foramen, so this positional variation is dramatically reduced. The ACCURATE trial specifically documented less postural variation with DRG compared to traditional spinal cord stimulation, which patients consistently describe as a meaningful quality-of-life advantage during everyday movement.
Higher Treatment Success Rates for CRPS and Focal Neuropathic Pain
The strongest comparative evidence for DRG comes from the ACCURATE trial in Pain, which showed treatment success rates of 81.2% with DRG versus 55.7% with traditional spinal cord stimulation at 3 months in patients with CRPS and causalgia of the lower extremities, with benefits sustained at 12 months. A multicenter real-world registry of 217 patients in Neuromodulation 2019 identified predictors of trial success, including how much of the painful area was covered by paresthesia during programming. Results are strongest for focal neuropathic pain distributions where anatomical precision matters most, and outcomes vary for other pain conditions, which is why proper patient selection is so important. I direct patients curious about the broader landscape to my page on spinal cord stimulation and advanced neuromodulation options.
Clinical Applications: When DRG Becomes the Better Choice
Patients often ask me, "Is my pain really the right fit for DRG?" The honest answer depends on pattern, character, and distribution.
CRPS affecting an extremity is the most established indication. Current ASIPP 2025 CRPS guidance discusses dorsal root ganglion stimulation as an evidence-based option for patients not responding to conservative care. Post-surgical focal neuropathic pain, especially groin pain after hernia repair or other pelvic procedures, is another strong application supported by the 2017 Neuromodulation cohort cited above. For carefully selected non-operated discogenic low back pain, a small prospective study in Neuromodulation 2020 reported a 68.3% average pain reduction at 12 months. Targeted L2-L3 DRG stimulation has also been studied in patients with low back pain after failed back surgery: in a Pain Practice 2018 trial, more than half of patients achieved at least 50% pain relief in the low back.
These are smaller studies in narrow patient populations, so candidacy is not automatic. The common thread is that DRG works best when pain is focal, neuropathic, and maps to a specific dermatomal distribution. Diffuse, multi-region pain remains an indication where traditional spinal cord stimulation may still be preferred. For patients curious about how interventional options sit within a broader plan, my page on comprehensive chronic pain management is a useful starting point.
DRG Therapy for Active Adults in Napa Valley: Precision Pain Relief for Wine Country Living
Focal pain in one foot, one knee, or one groin region rarely stays neatly contained, it changes how you stand at the harvest table, how long you can drive between vineyard properties, and whether a Saturday hike feels worth it. For Wine Country residents managing focal neuropathic pain, the postural stability of DRG can mean steady relief whether you are standing through a busy hospitality shift, sitting through a long meeting, or finally walking the Vine Trail again without rationing your steps.
Active adults in St. Helena dealing with post-surgical groin pain face the same core problem as professionals recovering from a sports-related foot CRPS in Yountville. Retirees on uneven garden paths in Calistoga share it too. The pain is focal, neuropathic, and frustratingly resistant to standard care. Access to advanced neuromodulation expertise locally means you can complete the evaluation, trial, and ongoing management without traveling to San Francisco or Sacramento.
When Should You Consider a DRG Evaluation?
This is the conversation I have with patients almost every week, and it is less about whether you have "tried everything" and more about whether your pain pattern matches what DRG is actually designed to treat. Consider asking about DRG stimulation if any of these apply to you:
DRG Candidacy Indicators
You have focal neuropathic pain in a specific region (foot, knee, groin, hand) that has been diagnosed as CRPS, post-surgical neuropathic pain, or another focal nerve injury.
You have already tried conservative care including medications, physical therapy, and possibly nerve blocks without enough lasting relief.
Your pain meaningfully limits activities or functions you care about, and you are looking for options beyond ongoing medication management.
You have been told you might be a candidate for spinal cord stimulation, but your pain is very localized rather than diffuse.
If you are living with focal neuropathic pain that is affecting your quality of life despite appropriate conservative care, that is reason enough to explore whether you are a candidate. Together, we will figure out whether your pain pattern is the right fit, or whether a different interventional path makes more sense.
What to Expect During a DRG Evaluation at Our Napa Practice
The evaluation starts with a detailed pain history and physical examination, a careful review of prior treatments and imaging, and a clear conversation about what has and has not worked. I assess pain distribution, character, and dermatomal pattern to determine whether DRG is anatomically appropriate for your specific pain location. Where useful, I review EMG studies or advanced imaging to confirm the focal neuropathic nature of pain.
If you are a candidate, the process moves in two stages. The first is a trial period in which temporary leads are placed under local sedation and an external generator is worn for a brief period, typically about a week, so we can confirm meaningful pain relief. The standard goal is at least a 50% improvement, the threshold used in the ACCURATE trial and broader clinical practice. Permanent implantation is only considered when the trial demonstrates that level of relief.
The trial is the decision point. It lets you and me, working together, confirm DRG actually works for your specific pain before you commit to a permanent implant. Most evaluations take 45 to 60 minutes, and you leave with a clear understanding of whether DRG is appropriate and what the next steps would involve. For patients arriving from outside the immediate area, my staff coordinates appointments to limit travel time.
DRG Stimulation vs. Traditional Spinal Cord Stimulation: A Side-By-Side View
| Feature | DRG Stimulation | Traditional Spinal Cord Stimulation |
|---|---|---|
| Target location | Dorsal root ganglion (sensory nerve cluster just outside the spinal cord) | Dorsal columns of the spinal cord |
| Coverage pattern | Focal, dermatomal; targets specific pain regions | Broader coverage along spinal segments |
| Postural stability | Minimal variation with position changes | Coverage may vary with body position |
| Best suited for | Focal pain in foot, knee, groin, hand; CRPS in a specific limb | Diffuse pain across larger regions or multiple dermatomes |
| Trial process | Brief external trial before permanent implant decision | Brief external trial before permanent implant decision |
| Evidence for CRPS | Higher treatment-success rates in lower-extremity CRPS (ACCURATE trial) | Established option with a long clinical track record across neuropathic pain conditions |
In Patients' Own Words
When patients describe what advanced interventional care has meant for them, the message I hear most often is about being listened to and given honest options. A long-time patient, Kathleen, shared her experience with my care after years of chronic nerve pain following an old injury.
"She is honest and forthcoming with all knowledge surrounding the care she gives you, the necessary treatments, the medicine, whatever it may be... kind, compassionate and caring..."
- Kathleen
Excerpt from a publicly shared patient review. Individual experiences vary.
Individual experiences vary, but Kathleen's note captures what I aim to provide: a clear-eyed conversation about your options, honest information about likely benefits and limits, and a plan that treats your specific pain pattern rather than a generic protocol.
Taking the Next Step Toward Targeted Relief for Focal Neuropathic Pain
DRG stimulation is a meaningful shift toward anatomical precision in neuromodulation, matching the therapy's target to the actual location of focal neuropathic pain. For patients with CRPS, post-surgical focal pain, or other localized neuropathic conditions affecting the foot, knee, groin, or hand, dorsal root ganglion stimulation offers advantages in targeting and postural stability that traditional spinal cord stimulation often cannot match. The strongest evidence is in focal lower-extremity neuropathic pain, and proper patient selection through a thorough evaluation remains essential.
If you are in Napa Valley or the broader Wine Country and you are managing focal neuropathic pain that is limiting your function despite appropriate conservative care, I would welcome the chance to evaluate whether DRG is right for you. You can schedule a consultation directly through my office, and we will work through your history, imaging, and pain pattern together. Results vary by individual, and the goal of any evaluation is an honest, personalized answer.
Ready to Explore Whether DRG Stimulation Fits Your Focal Pain Pattern?
Call my office at 707.603.1078 or visit drweisbein.com to talk through whether dorsal root ganglion stimulation is a candidate option for your specific pain pattern.
Ready to Discuss DRG Stimulation in Napa Valley?
Schedule a consultation to explore personalized interventional pain management options designed for your specific pain pattern.
Schedule Your Consultation →This article is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment. The information presented reflects an interventional pain management perspective and is intended to support, not substitute, your relationship with a qualified healthcare provider. Individual results vary based on diagnosis, pain duration, overall health, and response to treatment. Some procedures may not be covered by insurance. Treatment outcomes depend on proper patient selection and accurate diagnosis. Spinal cord stimulation and DRG stimulation require surgical implantation and are typically considered after more conservative treatments have been tried. Not all patients are candidates for this therapy. Always consult a board-certified physician before pursuing any pain management treatment.
Jackie Weisbein, DO · Napa Valley Orthopaedic Medical Group
Board-Certified in Physical Medicine & Rehabilitation and Pain Medicine · Fellowship-Trained Interventional Pain Specialist · Napa Valley Orthopaedic Medical Group
